参考文献/References:
[1]Gogas BD,Garcia-Garcia HM,Onuma Y,et al. Edge vascular response after percutaneous coronary intervention:an intracoronary ultrasound and optical coherence tomography appraisal:from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds[J]. JACC Cardiovasc Interv,2013,6(3):211-221.
[2] Moussa ID,Mohananey D,Saucedo J,et al. Trends and outcomes of restenosis after coronary stent implantation in the United States[J]. J Am Coll Cardiol,2020,76(13):1521-1531.
[3] Kozuma K,K ozuma K,S hinozaki T,et al. Multivariable prediction model to estimate the probability of restenosis at proximal edge after 2nd-generation drug-eluting-stent implantation:development and internal validation using a quantitative coronary angiography from the post-marketing surveillance studies of everolimus-eluting stent in Japan[J]. Cardiovasc Interv Ther,2021,36(2):190-197.
[4] Otake H. Stent Edge restenosis —An inevitable drawback of stenting?[J]. Circ J,2021,85(11):1969-1971.
[5] Shlofmitz E,I antorno M,W aksman R. Restenosis of drug-eluting stents:a new classification system based on disease mechanism to guide treatment and state-of-the-art review[J]. Circ Cardiovasc Interv,2019,12(8):e7023.
[6] van der Giessen WJ,Regar E,Harteveld MS,et al. "Edge Effect" of (32)p radioactive stents is caused by the combination of chronic stent injury and radioactive dose falloff[J]. Circulation,2001,104(18):2236-2241.
[7] Mehran R,Dangas G,Abizaid AS,et al. Angiographic patterns of in-stent restenosis:classification and implications for long-term outcome[J]. Circulation,1999,100(18):1872-1878.
[8] Nakazawa G,Otsuka F,Nakano M,et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents[J]. J Am Coll Cardiol,2011,57(11):1314-1322.
[9] Aoki J,Tanabe K. Mechanisms of drug-eluting stent restenosis[J]. Cardiovasc Interv Ther,2021,36(1):23-29.
[10]Song L,Mintz GS,Yin D,et al. Characteristics of early versus late in-stent restenosis in second-generation drug-eluting stents:an optical coherence tomography study[J]. EuroIntervention,2017,13(3):294-302.
[11]Byrne RA,Joner M,Kastrti A. Stent thrombosis and restenosis:what have we learned and where are we going?The Andreas Gruntzig Lecture ESC 2014[J]. Eur Heart J,2015,36(47):3320-3331.
[12]Claessen BE,Beijk MA,Legrand V,et al. Two-year clinical,angiographic,and intravascular ultrasound follow-up of the XIENCE Ⅴ everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions:the SPIRIT Ⅱ trial[J]. Circ Cardiovasc Interv,2009,2(4):339-347.
[13]Shimohama T,Ako J,Yamasaki M,et al. SPIRIT Ⅲ JAPAN versus SPIRIT Ⅲ USA:a comparative intravascular ultrasound analysis of the everolimus-eluting sten t[J]. Am J Cardiol,2010,106(1):13-17.
[14]Mintz GS,Garcia-Garcia HM,Nicholls SJ,et al. Clinical expert consensus document on standards for acquisition,measurement and reporting of intravascular ultrasound regression/progression studies[J]. EuroIntervention,2011,6(9):1123-1130.
[15]Ino Y,Kubo T,Matsuo Y,et al. Optical coherence tomography predictors for edge restenosis after everolimus-eluting stent implantation[J]. Circ Cardiovasc Interv,2016,9(10):e004231.
[16]Johnson TW,Raber L,di Mario C,et al. Clinical use of intracoronary imaging. Part 2:acute coronary syndromes,ambiguous coronary angiography findings,and guiding interventional decision-making:an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions[J]. Eur Heart J,2019,40(31):2566-2584.
[17]Xu B,Tu S,Song L,et al. Angiographic quantitative flow ratio-guided coronary intervention (FAVOR Ⅲ China):a multicentre,randomised,sham-controlled trial[J]. Lancet,2021,398(10317): 2149-2159.
[18]Meng PN,Liu B,Li LB,et al. Cut-off values of lesion and vessel quantitative flow ratio in de novo coronary lesion post-drug-coated balloon therapy predicting vessel restenosis at mid-term follow-up[J]. Chin Med J (Engl),2021,134(12):1450-1456.
[19]You W,Zhou Y,Wu Z,et al. Post-PCI quantitative flow ratio predicts 3-year outcome after rotational atherectomy in patients with heavily calcified lesions[J]. Clin Cardiol,2022,45(5):558-566.
[20]Chu M,Jia H,Gutierrez-Chico JL,et al. Artificial intelligence and optical coherence tomography for the automatic characterisation of human atherosclerotic plaques[J]. EuroIntervention,2021,17(1):41-50.
[21]Zeng X,Holck EN,Westra J,et al. Impact of coronary plaque morphology on the precision of computational fractional flow reserve derived from optical coherence tomography imaging[J]. Cardiovasc Diagn Ther,2022,12(2):155-165.
[22]Nong JC,You W,Xu T,et al. Dynamic natural morphologies and component changes in nonculprit subclinical atherosclerosis in patients with acute coronary syndrome at 1-year follow-up and clinical significance at 3-year follow-up[J]. Atherosclerosis,2022,53(7):1-8.
[23]Cheneau E,Wolfram R,Leborgne L,et al. Understanding and preventing the edge effect[J]. J Interv Cardiol,2003,16(1):1-7.
[24]Hoffmann R,Mintz GS,Kent KM,et al. Serial intravascular ultrasound predictors of restenosis at the margins of Palmaz-Schatz stents[J]. Am J Cardiol,1997,79(7):951-953.
[25]Ichimoto E,Fujimoto Y,Kubo K,et al. Mechanism of edge restenosis after sirolimus-eluting stent implantation[J]. J Invasive Cardiol,2012,24(2):55-57.
[26]Vernhet H,Demaria R,Pérez-Martin A,et al. Wall mechanics of the stented rabbit aorta:long-term study and correlation with histological findings[J]. J Endovasc Ther,2003,10(3):577-584.
[27]Wentzel JJ,Whelan dm,van der Giessen WJ,et al. Coronary stent implantation changes 3-D vessel geometry and 3-D shear stress distribution[J]. J Biomech,2000,33(10):1287-1295.
[28]Thury A,Wentzel JJ,Vinke RV,et al. Images in cardiovascular medicine. Focal in-stent restenosis near step-up:roles of low and oscillating shear stress?[J]. Circulation,2002,105(23):e185-e187.
[29]Xu T,You W,Wu ZM,et al. Retrospective analysis of OCT on MB characteristics and 1-year follow-up of the ISR incidence after the DES implantation in patients with MB[J]. Sci Rep,2022,12(1):534.
[30]Jimba T,Ikutomi M,Tsukamoto A,et al. Effect of hinge motion on stent edge-related restenosis after right coronary artery treatment in the current drug-eluting stent era[J]. Circ J,2021,85(11):1959-1968.
[31]Popma JJ,Leon MB,Moses JW,et al. Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries[J]. Circulation,2004,110(25):3773-3780.
[32]Kang SJ,Cho YR,Park GM,et al. Intravascular ultrasound predictors for edge restenosis after newer generation drug-eluting stent implantation[J]. Am J Cardiol,2013,111(10):1408-1414.
[33]Jiménez-Quevedo P,Sabaté M,Angiolillo DJ,et al. Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients:three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial[J]. J Am Coll Cardiol,2006,47(11):2172-2179.
[34]Jensen LO,Maeng M,Mintz GS,et al. Serial intravascular ultrasound analysis of peri-stent remodeling and proximal and distal edge effects after sirolimus-eluting or paclitaxel-eluting stent implantation in patients with diabetes mellitus[J]. Am J Cardiol,2009,103(8):1083-1088.
[35]Lemos PA,Saia F,Ligthart JM,et al. Coronary restenosis after sirolimus-eluting stent implantation:morphological description and mechanistic analysis from a consecutive series of cases[J]. Circulation,2003,108(3):257-260.
[36]Costa MA,Angiolillo DJ,Tannenbaum M,et al. Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial)[J]. Am J Cardiol,2008,101(12):1704-1711.
[37]Uemura S,Ishigami K,Soeda T,et al. Thin-cap fibroatheroma and microchannel findings in optical coherence tomography correlate with subsequent progression of coronary atheromatous plaques[J]. Eur Heart J,2012,33(1):78-85.
[38]Kozuma K,Shinozaki T,Kozuma K,et al. Impact of residual stenosis on the angiographic edge restenosis of a second-generation drug-eluting stent[J]. Int Heart J,2019,60(5):1050-1060.
[39]Alfonso F,Pérez-Vizcayno MJ,Gómez-Recio M,et al. Implications of the "watermelon seeding" phenomenon during coronary interventions for in-stent restenosis[J]. Catheter Cardiovasc Interv,2005,66(4):521-527.
[40]Aoki J,Nakazawa G,Ando K,et al. Effect of combination of non-slip element balloon and drug-coating balloon for in-stent restenosis lesions (ELEGANT study)[J]. J Cardiol,2019,74(5):436-442.
[41]Choi SY,Witzenbichler B,Maehara A,et al. Intravascular ultrasound findings of early stent thrombosis after primary percutaneous intervention in acute myocardial infarction:a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) substudy[J]. Circ Cardiovasc Interv,2011,4(3):239-247.
[42]Radu MD,Raber L,Heo J,et al. Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantation[J]. EuroIntervention,2014,9(9):1085-1094.
[43]van Zandvoort LJC,Tomaniak M,Tovar Forero MN,et al. Predictors for clinical outcome of untreated stent edge dissections as detected by optical coherence tomography[J]. Circ Cardiovasc Interv,2020,13(3):e8685.
[44]Jinnouchi H,Sakakura K,Yanase T,et al. Impact of stent edge dissection detected by optical coherence tomography after current-generation drug-eluting stent implantation[J]. PLoS One,2021,16(11):e0259693.
[45]Goto K,Zhao Z,Matsumura M,et al. Mechanisms and patterns of intravascular ultrasound in-stent restenosis among bare metal stents and first- and second-generation drug-eluting stents[J]. Am J Cardiol,2015,116(9):1351-1357.
[46]Mintz GS,Guagliumi G. Intravascular imaging in coronary artery disease[J]. Lancet,2017,390(10096):793-809.
[47]Jeger RV,Eccleshall S,Wan Ahmad WA,et al. Drug-coated balloons for coronary artery disease:third report of the international DCB consensus group[J]. JACC Cardiovasc Interv,2020,13(12):1391-1402.
[48]Alfonso F,Coughlan JJ,Giacoppo D,et al. Management of in-stent restenosis[J]. EuroIntervention,2022,18(2):e103-e123.
相似文献/References:
[1]何晨,综述,袁晋青,等.冠状动脉支架置入术后再狭窄的治疗研究进展[J].心血管病学进展,2016,(4):350.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.006]
HE Chen,YUAN Jinqing.Current Treatment of In-stent Restenosis[J].Advances in Cardiovascular Diseases,2016,(12):350.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.006]
[2]陆鑫 张华.无载体含药物洗脱支架研究进展1[J].心血管病学进展,2019,(7):1032.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.017]
LU xinZHANG Hua.Polymer-free Drug-eluting Stent[J].Advances in Cardiovascular Diseases,2019,(12):1032.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.017]
[3]陈彭辉 李军山 何晋.血管内超声指导冠状动脉复杂病变的介入治疗进展[J].心血管病学进展,2020,(11):1140.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
CHEN Penghui,LI Junshan,HE Jin.Interventional Therapy for Complex Coronary Artery Lesions Guided by Intravascular Ultrasound[J].Advances in Cardiovascular Diseases,2020,(12):1140.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[4]牛梦瑶 胡晓惠 张静.冠状动脉小血管病变中药物球囊的应用进展[J].心血管病学进展,2022,(1):68.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.018]
NIU Mengyao,HU Xiaohui,ZHANG Jing.Application of Drug Balloon in Coronary Small Vessel Disease[J].Advances in Cardiovascular Diseases,2022,(12):68.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.018]
[5]赵代鑫?胡晓军?谭巨浪?裴畅.基于Meta分析对比药物涂层球囊与药物洗脱支架在细小冠状动脉疾病中的应用[J].心血管病学进展,2022,(1):82.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.021]
ZHAO Daixin,HU Xiaojun,TAN Julang,et al.Comparison of Application of Drug-Coated Balloon and Drug-Eluting Stent in Small Coronary Artery Disease Based on Meta Analysis[J].Advances in Cardiovascular Diseases,2022,(12):82.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.021]
[6]袁晓航 冯欢欢 高磊.复发性支架内再狭窄的研究进展[J].心血管病学进展,2022,(8):677.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.002]
YUAN Xiaohang FENG Huanhuan GAO Lei.Recurrent In-Stent Restenosis[J].Advances in Cardiovascular Diseases,2022,(12):677.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.002]
[7]周昌颐 王瑞 沈雳.血管支架植入对血管平滑肌细胞的影响[J].心血管病学进展,2023,(4):299.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.003]
ZHOU Changyi,WANG Rui,SHEN Li.Impact of Vascular Stent Implantation on Vascular Smooth Muscle Cells[J].Advances in Cardiovascular Diseases,2023,(12):299.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.003]
[8]刘玉莹,杨斌.PCI术后损伤血管再内皮化延迟的机制与治疗研究综述[J].心血管病学进展,2024,(3):248.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.013]
LIU Yuying,YANG Bin.A Review of the mechanism and therapy of delayed re-endothelialization of injured vessels after PCI[J].Advances in Cardiovascular Diseases,2024,(12):248.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.013]